Galapagos NV
GLPG
#4956
Rank
โ‚ฌ1.60 B
Marketcap
23,89ย โ‚ฌ
Share price
0.00%
Change (1 day)
-5.58%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): โ‚ฌ0.47 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚ฌ1.22 Billion. In 2025 the company made an earning of โ‚ฌ0.30 Billion, an increase over its 2024 earnings that were of -โ‚ฌ3.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.47 B56.61%
2025 โ‚ฌ0.30 B-9852.71%
2024 -โ‚ฌ3.09 Million-89.44%
2023 -โ‚ฌ29.22 Million-86.42%
2022 -โ‚ฌ0.22 Billion74.92%
2021 -โ‚ฌ0.13 Billion-60.87%
2020 -โ‚ฌ0.32 Billion-309.49%
2019 โ‚ฌ0.15 B-613.74%
2018 -โ‚ฌ29.21 Million-74.71%
2017 -โ‚ฌ0.12 Billion-312.93%
2016 โ‚ฌ54.24 M-145.35%
2015 -โ‚ฌ0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.38 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ7.01 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ5.68 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.59 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ11.33 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.63 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ8.62 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚ฌ46.08 Million-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.95 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel